Mergers and Acquisitions

AstraZeneca acquires Fusion Pharmaceuticals in $2 billion deal

March 20, 2024 - On March 19, 2024, AstraZeneca entered into a definitive agreement to acquire Fusion Pharmaceuticals in a $2 billion deal. Through this deal, AstraZeneca will expand its portfolio and gain access to Fusion’s clinical-stage, next-generation radioconjugates and research that have been used in oncology treatments. According to the American...

Read More


More Articles

Gilead Announced Plans to Acquire CymaBay in a $4.3 Billion Deal

by Veronica Salib

On Monday, February 12, 2024, Gilead Sciences, a major pharmaceutical manufacturer, announced its plans to acquire CymaBay Therapeutics, a clinical-stage biopharmaceutical company with a strong liver...

Roche Expands Obesity Portfolio Through $2.7 Billion Carmot Acquisition

by Veronica Salib

On December 4, 2023, Roche revealed that it entered into definitive merger agreements with Carmot Therapeutics. According to the company’s press release, it will acquire Carmot and its gamut of...

Exploring Business Development Strategies for Pharma Startups

by Alivia Kaylor

Pharmaceutical startups face significant challenges in the ever-evolving healthcare industry. A 2020 Drug Discovery Today article emphasized that these challenges often result from unclear business models, the absence of a go-to-market...

Abbott Plans to Acquire Bigfoot Biomedical, Growing Diabetes Portfolio

by Veronica Salib

Last week, Abbott announced plans to acquire Bigfoot Biomedical in the third quarter of 2023. If successful, this acquisition could significantly enhance Abbott’s diabetes management portfolio,...

FTC’s Lawsuit Against Amgen Horizon Deal to Reach Court in September

by Hayden Schmidt

Federal Trade Commission (FTC) officials are taking Amgen and Horizon to court this September to block a prospective pharmaceutical acquisition of the two companies. The FTC announced that it planned...

GSK Acquires Bellus Health for $2 Billion

by Hayden Schmidt

On Tuesday, GSK announced that it had reached an agreement to acquire Bellus Health Inc. for nearly $2 billion. Bellus, a Canada-based biopharmaceutical company, will provide GSK access to camlipixant,...

Merck Plans to Acquire Prometheus Biosciences in a $10.8 Billion Deal

by Veronica Salib

On April 16, 2023, Merck announced plans to expand its immunology portfolio by acquiring Prometheus Biosciences, a biotechnology company focused on immune-mediated diseases. The deal, valued at $10.8...

Sanofi Acquires Provention Bio for $2.9 Billion

by Hayden Schmidt

On Monday, the European healthcare company Sanofi announced a $2.9 billion acquisition deal with US-based Provention Bio. Under the terms of the agreement, Sanofi will pay $25 per share in cash,...

A Closer Look at the Most Recent Pfizer Acquisition Deal: Seagen Inc

by Veronica Salib

Recently, Pfizer Inc, a leading pharmaceutical manufacturer in the United States, confirmed plans to acquire Seagen, a smaller manufacturer focused on oncology medications, to expand its oncology portfolio, Pfizer Oncology. The recent...

Pfizer Confirms $43B Seagen Acquisition Deal

by Veronica Salib

After speculation about acquisition deals earlier this month, Pfizer Inc has officially confirmed its acquisition of Seagen Inc. The $43 billion deal was a strategic move by Pfizer to expand the...

Pfizer Considers Potential $40B Seagen Acquisition

by Hayden Schmidt

Pfizer Inc is reportedly in talks to buy the cancer drugmaker Seagen Inc after a potential acquisition by Merck last year fell through. In August 2022, it was reported that Merck was considering a $40...

Sun Pharmaceutical Industries Acquires Concert Pharma for $576M

by Hayden Schmidt

Last month, Sun Pharma announced that it would pay $8 per share to acquire Concert for a total of $576 million in cash. During the first three quarters of 2022, Concert recorded a net loss of nearly...

Envision Pharma Group Acquires OKRA.ai

by Hayden Schmidt

This week, Envision Pharma Group announced that it had acquired OKRA.ai, a leader in artificial intelligence solutions for pharmaceutical operations. The transaction will add OKRA’s founder to...

Senator Targets Amgen and Indivior Acquisitions for Antitrust Action

by Hayden Schmidt

Last week, the Senator from Massachusetts, Elizabeth Warren, penned a letter to the Federal Trade Commission (FTC) where she characterized recent consolidation in the pharmaceutical industry as a...

Pfizer Acquires Abzena’s Biologic Manufacturing Facility

by Hayden Schmidt

The contract development and manufacturing organization (CDMO) Abzena and Pfizer’s CDMO arm CenterOne reached an agreement last week, under which Pfizer will take control of Abzena’s...

AstraZeneca Purchases CinCor Pharma Inc. in $1.8 Billion Acquisition

by Hayden Schmidt

This week, AstraZeneca announced its acquisition of Massachusetts-based CinCor Pharma as part of a transaction worth $1.8 billion. CinCor will support AstraZeneca’s mission to accelerate...

Amgen’s $27.8 Billion Rare Disease Drug Acquisition

by Hayden Schmidt

On Monday, Amgen Inc announced its acquisition of the rare disease pharmaceutical company Horizon Therapeutics PLC, building on its portfolio of key drugs for treating uncommon conditions. Amgen...

Eli Lilly Acquires Akouos in Approximately $487 Million Transaction

by Veronica Salib

In a recent press release from Eli Lilly and Company, the company announced that it had completed the acquisition of Akouos. Earlier this year, on October 18, 2022, Lilly announced plans to acquire the...

Citeline and Norstella Merger Creates $5B Pharmaceutical Technology Company

by Hayden Schmidt

Norstella, a leading pharmaceutical solutions provider, completed its merger with Citeline earlier this month. As a result of the merger, Citeline will join Norstella’s group of brands, including...

Recent Articles